SEC Form 4 · accession 0001193805-18-000828
Protara Therapeutics, Inc. · TARA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Jonathan S Leff
Director
Period of report
Jun 8, 2018
Accepted (ET)
Jun 12, 2018 · 2:45 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001359931
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F1,F2 | $2.50 | Jun 8, 2018 | A | 12,700 | A | — | Jun 7, 2028 | Common Stock | 12,700 | 12,700 | D |
Explanation of responses
- F1The Reporting Person, a partner in Deerfield Management Company, L.P., has no pecuniary interest in the securities reported herein and disclaims beneficial ownership of such securities. The Reporting Person holds the option for the benefit, and at the direction, of Deerfield Management Company, L.P.
- F2The option shall vest and become exercisable with respect to 100% of the shares on the earlier of (i) June 8, 2019 and (ii) the next annual meeting of stockholders of the Issuer.